Related Experiment Videos

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

K Polyak1, J Y Kato, M J Solomon

  • 1Cell Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

Genes & Development
|January 1, 1994
PubMed

Insights

Cell cycle arrest in G1 is mediated by an inhibitor protein (p27) that blocks cyclin E-Cdk2 complex activation. Cyclin D2-Cdk4 complexes may reverse this inhibition, allowing cell cycle progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cell-cell contact and TGF-beta induce G1 cell cycle arrest.
  • During arrest, cyclin E-Cdk2 complexes are inactive.
  • This inactivity is linked to elevated thresholds for cyclin E-Cdk2 activation.

Purpose of the Study:

  • To identify the molecular mechanisms underlying G1 cell cycle arrest.
  • To investigate the role of specific inhibitors in regulating cyclin E-Cdk2 activity.
  • To elucidate the pathway that reverses cell cycle arrest.

Main Methods:

  • Cell cycle synchronization and arrest.
  • Biochemical assays to assess cyclin E-Cdk2 complex activity.
  • Affinity chromatography using cyclin E-Cdk2 to purify interacting proteins.
  • Western blotting to detect protein levels and interactions.

Main Results:

  • A 27-kD inhibitor protein (p27) was purified from arrested cells but not proliferating cells.
  • p27 binds to and inhibits cyclin E-Cdk2 complex activation.
  • p27 is present in proliferating cells but sequestered.
  • Cyclin D2-Cdk4 complexes down-regulate p27 activity.

Conclusions:

  • p27 is a key inhibitor of cyclin E-Cdk2 activation during G1 arrest.
  • The sequestration of p27 in proliferating cells allows cell cycle progression.
  • Cyclin D2-Cdk4 complexes play a role in reversing p27-mediated inhibition and promoting G1 progression.

Related Concept Videos